Explore All Access
Check if your research matches the topics covered in Oncology Letters?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Oncology Letters : Impact Factor & More
eISSN: 1792-1082pISSN: 1792-1074
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Oncology Letters Key Metrics
CiteScore 
5.8
SNIP
0.73
Topics Covered on Oncology Letters
Cancer
Western blot
Lung cancer
Overall survival
Lymph node
Reactive oxygen species
Computed tomography
Neuroendocrine tumors
Hepatocellular carcinoma
Arsenic
Cell cycle
Radiation
Cisplatin
Growth factor
Gene expression
Cell migration
Breast cancer
Lung
Osteosarcoma
Survival rate
Oncology Letters Journal Specifications
| Overview | |
| Publisher | SPANDIDOS PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncology Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncology Letters
Erratum: [Corrigendum] Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression via the p38MAPK signaling pathway.
- 1 Jan 2025
- Oncology letters
Metastasis of clear cell renal cell carcinoma to hyalinizing trabecular tumor of the thyroid: A case report
- 18 Dec 2024
- Oncology Letters
Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real‑world data
- 17 Dec 2024
- Oncology Letters
Development of a predictive model for immune‑related adverse events in patients with cancer
- 17 Dec 2024
- Oncology Letters
Retracted] Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
- 17 Dec 2024
- Oncology Letters
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
- 10 Dec 2024
- Oncology Letters
Erratum: [Corrigendum] Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression via the p38MAPK signaling pathway.
- 1 Jan 2025
- Oncology letters
Metastasis of clear cell renal cell carcinoma to hyalinizing trabecular tumor of the thyroid: A case report
- 18 Dec 2024
- Oncology Letters
Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real‑world data
- 17 Dec 2024
- Oncology Letters
Development of a predictive model for immune‑related adverse events in patients with cancer
- 17 Dec 2024
- Oncology Letters
Retracted] Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
- 17 Dec 2024
- Oncology Letters
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
- 10 Dec 2024
- Oncology Letters
Compare Similar Journals with Oncology Letters
Select Journals to Compare with Oncology Letters
Total journals - 9
You can select up to 3 Journals at a time
Oncology Reports
Publisher: SPANDIDOS PUBL LTD
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Molecular Medicine Reports
Publisher: SPANDIDOS PUBL LTD
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Scientific Reports
Publisher: NATURE PORTFOLIO
EXPERIMENTAL AND THERAPEUTIC MEDICINE
Publisher: SPANDIDOS PUBL LTD
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
0 Journals Selected to compare with
Oncology Letters
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Oncology Letters
How long has Oncology Letters been actively publishing? 
Oncology Letters has been in operation since 2010 till date.
What is the publishing frequency of Oncology Letters?
Oncology Letters published with a Monthly frequency.
How many articles did Oncology Letters publish last year?
In 2023, Oncology Letters publsihed 552 articles.
What is the eISSN & pISSN for Oncology Letters?
For Oncology Letters, eISSN is 1792-1082 and pISSN is 1792-1074.
What is Citescore for Oncology Letters?
Citescore for Oncology Letters is 5.8.
What is SNIP score for Oncology Letters?
SNIP score for Oncology Letters is 0.73.
Who is the publisher of Oncology Letters?
SPANDIDOS PUBL LTD is the publisher of Oncology Letters.
